SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-13-261245
Filing Date
2013-06-17
Accepted
2013-06-17 16:01:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d554540d424b5.htm 424B5 465887
2 GRAPHIC g554540g44b77.jpg GRAPHIC 16002
3 GRAPHIC g554540g86z94.jpg GRAPHIC 13566
  Complete submission text file 0001193125-13-261245.txt   508109
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-189192 | Film No.: 13916861
SIC: 2834 Pharmaceutical Preparations